To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
about
Nanoparticle-based drug delivery systems: What can they really do in vivo?The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Liposomal Formulations in Clinical Use: An Updated Review.An overview of nanosomes delivery mechanisms: trafficking, orders, barriers and cellular effects.Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Synergy of Iron Chelators and Therapeutic Peptide Sequences Delivered via a Magnetic Nanocarrier.Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.Protein based therapeutic delivery agents: Contemporary developments and challenges.Poly-N-acryloyl-(l-phenylalanine methyl ester) hollow core nanocapsules facilitate sustained delivery of immunomodulatory drugs and exhibit adjuvant properties.The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems.The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.In Vivo Imaging of Prostate Cancer Tumors and Metastasis Using Non-Specific Fluorescent Nanoparticles in Mice.Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.Autonomous self-navigating drug-delivery vehicles: from science fiction to reality.Particle Targeting in Complex Biological Media.Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7-Ethyl-10-Hydroxycamptothecin.The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.Bioreducible nanocapsules for folic acid-assisted targeting and effective tumor-specific chemotherapy.Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery.Construction and application of a liver cancer-targeting drug delivery system based on core-shell gold nanocages.Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy.Magnetic targeting of paclitaxel-loaded poly(lactic--glycolic acid)-based nanoparticles for the treatment of glioblastomaEndogenously Triggerable Ultrasmall-in-Nano Architectures: Targeting Assessment on 3D Pancreatic Carcinoma SpheroidsEngineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in TumorTumor Microenvironment Targeted NanotherapyPLGA-Based Nanoparticles in Cancer Treatment
P2860
Q33772186-1D4404CA-E458-46C1-ABFD-7F6663A55978Q33815087-C2DAE090-A37D-48CF-8D64-EFA3C1944CAEQ33850427-5267F3B5-AD35-483F-8C34-2746DEE7ADE7Q38557213-2D423237-690D-4E0E-A2F1-7133F2C08988Q38658279-C028F52D-E2A3-4719-9F58-3FBD65EF6657Q38663657-852F7B87-FA24-4BDB-AF11-17C15AF46C23Q38676164-3475993B-E6A2-42B1-B902-BAB5FF3CDEC3Q38682486-780CE60B-1441-416A-BCF6-B804A83986BFQ38698236-D2B146E7-E6A4-4621-A7F7-1700396DBB0BQ38786095-43B8143F-D07D-4C56-8BAA-A5616B8CBC5AQ39273739-ABEB657F-7EC4-409E-B72E-4205A6D41176Q40054092-DE2312D6-ED1E-43A2-9D3E-0E58844BCA33Q41280225-B6D4CC8A-2294-4E14-BF60-EF79E4845779Q41518143-52A49156-32BA-470F-ACB8-141E716F38CDQ44395334-4CA61F24-D652-47D6-9E00-BFD8A473F30EQ45324119-5FEDB8A7-CEE7-4EA3-8C6D-3EABFA6E2ABFQ47172294-7F95E240-E261-4DC7-B016-637B73EB8860Q47276992-480B17DA-B1C1-4350-9960-C02FC4C43AC0Q47417419-0E005913-3C77-4159-858E-F44563B4D863Q47794249-5B91EC98-4A2C-4E72-9A0D-E242BCAED882Q48206548-992B1742-D201-46FD-A33B-0EBC9AC43A26Q48219725-4D5E78DB-2174-4E42-A741-42408CFEFF11Q48243945-0CCB11A2-7706-4B60-A9F1-18B4A3ACB937Q48558433-CC32AF1B-4EC3-4DD7-80F6-7CB3731DD202Q48610668-C12F65CD-C045-41F6-B1CF-16A482338129Q49529515-3C7E1069-B99F-42BC-83D5-03788BDFDB8BQ49678164-B885902F-DE83-42DE-AE21-1E59631B7DE6Q50070105-993EA224-7291-4827-A788-74FD715C3CD8Q50301013-BCEAF659-583B-47A5-8AD2-A47D26F8630DQ52347109-1E9314E2-7317-4D21-9F1C-E2D94F53C6C3Q52614698-2BC96211-516A-4630-9A12-E3FCFB533A01Q54118354-111B9FA4-2BB1-4B5A-B365-D4DFE5B4C833Q54970083-879CB156-251F-4AEF-BAA4-C2503651E2E0Q55150815-DFAC25DB-E6DF-47F8-BD23-913ACDC80BD0Q57181658-27E5140C-6FCD-41F9-9A7E-C6039B8F0C2CQ57489611-1CB9A2B5-721D-4B57-BD05-70DAC392605BQ58552610-BDB2E13B-14CE-43C4-8631-2FF7AD1E7B0BQ59133567-EB063049-A4E2-4B24-9D59-195C9FF1AB4DQ59137460-11B5130A-1F5E-4AD1-8FDF-535DDC9CCABD
P2860
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
To exploit the tumor microenvi ...... is the future of nanomedicine?
@ast
To exploit the tumor microenvi ...... is the future of nanomedicine?
@en
To exploit the tumor microenvi ...... is the future of nanomedicine?
@nl
type
label
To exploit the tumor microenvi ...... is the future of nanomedicine?
@ast
To exploit the tumor microenvi ...... is the future of nanomedicine?
@en
To exploit the tumor microenvi ...... is the future of nanomedicine?
@nl
prefLabel
To exploit the tumor microenvi ...... is the future of nanomedicine?
@ast
To exploit the tumor microenvi ...... is the future of nanomedicine?
@en
To exploit the tumor microenvi ...... is the future of nanomedicine?
@nl
P1476
To exploit the tumor microenvi ...... is the future of nanomedicine?
@en
P2093
P304
P356
10.1016/J.JCONREL.2016.11.015
P407
P577
2016-11-18T00:00:00Z